Frog (Xenopus laevis) cell line derived from subcutaneous tumor.
細胞特性(日)
カエル皮下腫瘍由来細胞株(Xenopus laevis)
細胞特性(寄託者記述:英)
細胞特性(寄託者記述:日)
使用条件(英)
1) A permission of the approver is required. 2) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Experientia 1992;48:87-91) designated by the DEPOSITOR is required.
Laboratory of Tissue Morphogenesis Biological Sciences, Faculty of Science and Engineering Chuo University E-mail. fukui.55m@g.chuo-u.ac.jp
Dr.FUKUI Akimasa
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
2211
Fukui A, Tashiro A, Koyama H, Iwamura Y, Asashima M
A new cell line (XTY) from a tumor of Xenopus laevisExperientia
1992
48:87-91
PubMed ID: 1737584
DOI: 10.1007/bf01923615